GABRQ expression is a potential prognostic marker for patients with clear cell renal cell carcinoma
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q4Scopus Q3
- 저널
- ONCOLOGY LETTERS18(6) · pp.5731 · 2019
- 피인용
- Web of Science 10Scopus 9
- FWCI (Scopus)
- 0.25
- JCR IF
- JCR 2018 1.871
- ISSN
- 1792-1074
저자
- 이동준제1저자Department of Convergence Medical Science, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 하미향Department of Anatomy, Pusan National University, School of Medicine, 49 Busandaehak-ro, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 홍채미Department of Convergence Medical Science, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 김자영Department of Convergence Medical Science, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 박수민Department of Convergence Medical Science, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- Park, DongsuDepartment of Molecular Human Genetics, Baylor College of Medicine, Houston, TX, 77030, USA
- 손동현Department of Microbiology and Immunology, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 신호진Department of Hematology-Oncology, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 유학선Department of Parasitology, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612
- 김치대Department of Pharmacology, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 강치덕Department of Biochemistry, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 한명은Department of Anatomy, Pusan National University, School of Medicine, 49 Busandaehak-ro, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 오세옥교신저자Department of Anatomy, Pusan National University, School of Medicine, 49 Busandaehak-ro, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
- 김윤학Biomedical Informatics, Pusan National University School of Medicine, Yangsan, Gyeongsangnam-do, 50612, Republic of Korea
초록
Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer. Novel biomarkers of ccRCC may provide crucial information on tumor features and prognosis. The present study aimed to determine whether the expression of gamma -aminobutyric acid (GABA) A receptor subunit theta (GABRQ) could serve as a novel prognostic marker of ccRCC. GABA is the main inhibitory neurotransmitter in the brain that activates the receptor GABA(A), which is comprised of three subunit isoforms: GABRA3, GABRB3 and GABRQ. A recent study reported that GABRQ is involved in the initiation and progression of hepatocellular carcinoma; however, the role of GABRQ in ccRCC remains unknown. In the present study, clinical and transcriptomic data were obtained from cohorts of the International Cancer Genome Consortium (ICGC) and The Cancer Genome Atlas (TCGA). Differential GABRQ expression levels among early (TI and II), late (TIII and IV), nonmetastatic (M0) and metastatic (M1, primary tumor) stages of ccRCC samples were then identified. Furthermore, the use of GABRQ as a prognostic gene was analyzed using Uno's C-index based on the time-dependent area under the curve (AUC), the AUC of the receiver operating characteristic curve at 5 years, the Kaplan-Meier survival curve and multivariate analysis. The survival curve analysis revealed that low GABRQ mRNA expression was significantly associated with a poor prognosis of ccRCC (P<0.001 and P=0.0012 for TCGA and ICGC data, respectively). In addition, analyses of the C-index and AUC values further supported this discriminatory power. Furthermore, the prognostic value of GABRQ mRNA expression was confirmed by multivariate Cox regression analysis. Taken together, these results suggested that GABRQ mRNA expression may be considered as a novel prognostic biomarker of ccRCC.
키워드
gamma-aminobutyric acid receptor A subunit thetaclear cell renal cell carcinomaprognosisThe Cancer Genome AtlasInternational Cancer Genome ConsortiumGAMMA-AMINOBUTYRIC-ACIDGENE-EXPRESSIONCANCERIDENTIFICATIONGUIDELINESRECEPTORSSURVIVALNETWORKASSAYVEGF
식별자
- Scopus EID
- 2-s2.0-85075688795
- WoS UID
- 000505576300009



로그인
연구물 목록으로